1. Home
  2. MTVA vs JCTC Comparison

MTVA vs JCTC Comparison

Compare MTVA & JCTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTVA
  • JCTC
  • Stock Information
  • Founded
  • MTVA 2014
  • JCTC 1953
  • Country
  • MTVA United States
  • JCTC United States
  • Employees
  • MTVA N/A
  • JCTC N/A
  • Industry
  • MTVA
  • JCTC
  • Sector
  • MTVA
  • JCTC
  • Exchange
  • MTVA NYSE
  • JCTC NYSE
  • Market Cap
  • MTVA 14.3M
  • JCTC 13.2M
  • IPO Year
  • MTVA N/A
  • JCTC 1996
  • Fundamental
  • Price
  • MTVA $0.71
  • JCTC $3.40
  • Analyst Decision
  • MTVA Strong Buy
  • JCTC
  • Analyst Count
  • MTVA 2
  • JCTC 0
  • Target Price
  • MTVA $7.50
  • JCTC N/A
  • AVG Volume (30 Days)
  • MTVA 64.8K
  • JCTC 17.0K
  • Earning Date
  • MTVA 08-13-2025
  • JCTC 07-14-2025
  • Dividend Yield
  • MTVA N/A
  • JCTC N/A
  • EPS Growth
  • MTVA N/A
  • JCTC N/A
  • EPS
  • MTVA N/A
  • JCTC N/A
  • Revenue
  • MTVA N/A
  • JCTC $44,141,421.00
  • Revenue This Year
  • MTVA N/A
  • JCTC N/A
  • Revenue Next Year
  • MTVA N/A
  • JCTC N/A
  • P/E Ratio
  • MTVA N/A
  • JCTC N/A
  • Revenue Growth
  • MTVA N/A
  • JCTC N/A
  • 52 Week Low
  • MTVA $0.60
  • JCTC $3.26
  • 52 Week High
  • MTVA $4.36
  • JCTC $5.41
  • Technical
  • Relative Strength Index (RSI)
  • MTVA N/A
  • JCTC N/A
  • Support Level
  • MTVA N/A
  • JCTC N/A
  • Resistance Level
  • MTVA N/A
  • JCTC N/A
  • Average True Range (ATR)
  • MTVA 0.00
  • JCTC 0.00
  • MACD
  • MTVA 0.00
  • JCTC 0.00
  • Stochastic Oscillator
  • MTVA 0.00
  • JCTC 0.00

About MTVA METAVIA INC

MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.

About JCTC JEWETT-CAMERON TRADING CO

Jewett-Cameron Trading Co Ltd through its subsidiaries engages in the wholesale distribution of a variety of specialty wood products. Its operating segments include, The Industrial wood products segment is engaged in the processing and distribution of industrial wood products. The Pet Fencing and Other segment, which is the key revenue driver, operates as a wholesaler of wood products and a manufacturer and distributor of specialty metal products. The Seed processing and sales segment processes and distributes agricultural seed and Corporate and administrative. The company predominantly operates in the United States and also has a presence in Canada, Latin America, Europe and Asia Pacific, and other regions.

Share on Social Networks: